The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Meglumine Diatrizoate Injection Market Research Report 2024

Global Meglumine Diatrizoate Injection Market Research Report 2024

Publishing Date : Jun, 2023

License Type :
 

Report Code : 1736840

No of Pages : 91

Ask Your Query

Synopsis
Meglumine injection, indicated as this contrast agent for intravenous and retrograde urography; Cerebral, thoracic, abdominal and limbs angiography, venography and CT; It can also be used for arthrography, fistula imaging, hysterosalpingography, endoscopic retrograde cholangiopancreatography (ERCP), sialography, and other tests. Meglumine injection should not be used in selective coronary angiography. It should not be used for myelography, ventriculography, or cisternography as it may induce neurotoxic symptoms.

Global Meglumine Diatrizoate Injection market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Meglumine Diatrizoate Injection market research.

The major consumer markets for Meglumine Diatrizoate Injection are North America, Europe and the Asia-Pacific region. With the gradual recovery of the global economy after the COVID-19 outbreak and the return of major economies to normal, the medical industry will see certain growth. As the global medical level continues to improve, more and more hospitals and clinics are able to perform MRI and CT imaging. Therefore, the demand for Meglumine Diatrizoate Injection will increase in the foreseeable time.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Meglumine Diatrizoate Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  • AdvaCare Pharma
  • Shanghai Xudong Haipu Pharmaceutical
  • Hunan Hansen Pharmaceutical
  • Shanghai Bracco Sine Pharmaceutical
  • Lunan Pharmaceutical
  • Xi'an Hanfeng Pharmaceutical

Segment by Type

  • 1ml/0.3g
  • 20ml/15.2g
  • 20ml/12g
  • 100ml/60g

Segment by Application

  • Hospital
  • Clinic
  • Pharmacy

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

The Meglumine Diatrizoate Injection report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Index

List of Tables
Table 1. Global Meglumine Diatrizoate Injection Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Meglumine Diatrizoate Injection Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Meglumine Diatrizoate Injection Market Competitive Situation by Manufacturers in 2022
Table 4. Global Meglumine Diatrizoate Injection Sales (K Bottles) of Key Manufacturers (2018-2023)
Table 5. Global Meglumine Diatrizoate Injection Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Meglumine Diatrizoate Injection Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Meglumine Diatrizoate Injection Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Meglumine Diatrizoate Injection Average Price (US$/Bottle) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Meglumine Diatrizoate Injection, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Meglumine Diatrizoate Injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Meglumine Diatrizoate Injection, Product Type & Application
Table 12. Global Key Manufacturers of Meglumine Diatrizoate Injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Meglumine Diatrizoate Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meglumine Diatrizoate Injection as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Meglumine Diatrizoate Injection Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Meglumine Diatrizoate Injection Sales by Region (2018-2023) & (K Bottles)
Table 18. Global Meglumine Diatrizoate Injection Sales Market Share by Region (2018-2023)
Table 19. Global Meglumine Diatrizoate Injection Sales by Region (2024-2029) & (K Bottles)
Table 20. Global Meglumine Diatrizoate Injection Sales Market Share by Region (2024-2029)
Table 21. Global Meglumine Diatrizoate Injection Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Meglumine Diatrizoate Injection Revenue Market Share by Region (2018-2023)
Table 23. Global Meglumine Diatrizoate Injection Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Meglumine Diatrizoate Injection Revenue Market Share by Region (2024-2029)
Table 25. North America Meglumine Diatrizoate Injection Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Meglumine Diatrizoate Injection Sales by Country (2018-2023) & (K Bottles)
Table 27. North America Meglumine Diatrizoate Injection Sales by Country (2024-2029) & (K Bottles)
Table 28. North America Meglumine Diatrizoate Injection Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Meglumine Diatrizoate Injection Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Meglumine Diatrizoate Injection Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Meglumine Diatrizoate Injection Sales by Country (2018-2023) & (K Bottles)
Table 32. Europe Meglumine Diatrizoate Injection Sales by Country (2024-2029) & (K Bottles)
Table 33. Europe Meglumine Diatrizoate Injection Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Meglumine Diatrizoate Injection Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Meglumine Diatrizoate Injection Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Meglumine Diatrizoate Injection Sales by Region (2018-2023) & (K Bottles)
Table 37. Asia Pacific Meglumine Diatrizoate Injection Sales by Region (2024-2029) & (K Bottles)
Table 38. Asia Pacific Meglumine Diatrizoate Injection Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Meglumine Diatrizoate Injection Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Meglumine Diatrizoate Injection Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Meglumine Diatrizoate Injection Sales by Country (2018-2023) & (K Bottles)
Table 42. Latin America Meglumine Diatrizoate Injection Sales by Country (2024-2029) & (K Bottles)
Table 43. Latin America Meglumine Diatrizoate Injection Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Meglumine Diatrizoate Injection Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Meglumine Diatrizoate Injection Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Meglumine Diatrizoate Injection Sales by Country (2018-2023) & (K Bottles)
Table 47. Middle East & Africa Meglumine Diatrizoate Injection Sales by Country (2024-2029) & (K Bottles)
Table 48. Middle East & Africa Meglumine Diatrizoate Injection Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Meglumine Diatrizoate Injection Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Meglumine Diatrizoate Injection Sales (K Bottles) by Type (2018-2023)
Table 51. Global Meglumine Diatrizoate Injection Sales (K Bottles) by Type (2024-2029)
Table 52. Global Meglumine Diatrizoate Injection Sales Market Share by Type (2018-2023)
Table 53. Global Meglumine Diatrizoate Injection Sales Market Share by Type (2024-2029)
Table 54. Global Meglumine Diatrizoate Injection Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Meglumine Diatrizoate Injection Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Meglumine Diatrizoate Injection Revenue Market Share by Type (2018-2023)
Table 57. Global Meglumine Diatrizoate Injection Revenue Market Share by Type (2024-2029)
Table 58. Global Meglumine Diatrizoate Injection Price (US$/Bottle) by Type (2018-2023)
Table 59. Global Meglumine Diatrizoate Injection Price (US$/Bottle) by Type (2024-2029)
Table 60. Global Meglumine Diatrizoate Injection Sales (K Bottles) by Application (2018-2023)
Table 61. Global Meglumine Diatrizoate Injection Sales (K Bottles) by Application (2024-2029)
Table 62. Global Meglumine Diatrizoate Injection Sales Market Share by Application (2018-2023)
Table 63. Global Meglumine Diatrizoate Injection Sales Market Share by Application (2024-2029)
Table 64. Global Meglumine Diatrizoate Injection Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Meglumine Diatrizoate Injection Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Meglumine Diatrizoate Injection Revenue Market Share by Application (2018-2023)
Table 67. Global Meglumine Diatrizoate Injection Revenue Market Share by Application (2024-2029)
Table 68. Global Meglumine Diatrizoate Injection Price (US$/Bottle) by Application (2018-2023)
Table 69. Global Meglumine Diatrizoate Injection Price (US$/Bottle) by Application (2024-2029)
Table 70. AdvaCare Pharma Corporation Information
Table 71. AdvaCare Pharma Description and Business Overview
Table 72. AdvaCare Pharma Meglumine Diatrizoate Injection Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2018-2023)
Table 73. AdvaCare Pharma Meglumine Diatrizoate Injection Product
Table 74. AdvaCare Pharma Recent Developments/Updates
Table 75. Shanghai Xudong Haipu Pharmaceutical Corporation Information
Table 76. Shanghai Xudong Haipu Pharmaceutical Description and Business Overview
Table 77. Shanghai Xudong Haipu Pharmaceutical Meglumine Diatrizoate Injection Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2018-2023)
Table 78. Shanghai Xudong Haipu Pharmaceutical Meglumine Diatrizoate Injection Product
Table 79. Shanghai Xudong Haipu Pharmaceutical Recent Developments/Updates
Table 80. Hunan Hansen Pharmaceutical Corporation Information
Table 81. Hunan Hansen Pharmaceutical Description and Business Overview
Table 82. Hunan Hansen Pharmaceutical Meglumine Diatrizoate Injection Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2018-2023)
Table 83. Hunan Hansen Pharmaceutical Meglumine Diatrizoate Injection Product
Table 84. Hunan Hansen Pharmaceutical Recent Developments/Updates
Table 85. Shanghai Bracco Sine Pharmaceutical Corporation Information
Table 86. Shanghai Bracco Sine Pharmaceutical Description and Business Overview
Table 87. Shanghai Bracco Sine Pharmaceutical Meglumine Diatrizoate Injection Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2018-2023)
Table 88. Shanghai Bracco Sine Pharmaceutical Meglumine Diatrizoate Injection Product
Table 89. Shanghai Bracco Sine Pharmaceutical Recent Developments/Updates
Table 90. Lunan Pharmaceutical Corporation Information
Table 91. Lunan Pharmaceutical Description and Business Overview
Table 92. Lunan Pharmaceutical Meglumine Diatrizoate Injection Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2018-2023)
Table 93. Lunan Pharmaceutical Meglumine Diatrizoate Injection Product
Table 94. Lunan Pharmaceutical Recent Developments/Updates
Table 95. Xi'an Hanfeng Pharmaceutical Corporation Information
Table 96. Xi'an Hanfeng Pharmaceutical Description and Business Overview
Table 97. Xi'an Hanfeng Pharmaceutical Meglumine Diatrizoate Injection Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2018-2023)
Table 98. Xi'an Hanfeng Pharmaceutical Meglumine Diatrizoate Injection Product
Table 99. Xi'an Hanfeng Pharmaceutical Recent Developments/Updates
Table 100. Key Raw Materials Lists
Table 101. Raw Materials Key Suppliers Lists
Table 102. Meglumine Diatrizoate Injection Distributors List
Table 103. Meglumine Diatrizoate Injection Customers List
Table 104. Meglumine Diatrizoate Injection Market Trends
Table 105. Meglumine Diatrizoate Injection Market Drivers
Table 106. Meglumine Diatrizoate Injection Market Challenges
Table 107. Meglumine Diatrizoate Injection Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Meglumine Diatrizoate Injection
Figure 2. Global Meglumine Diatrizoate Injection Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Meglumine Diatrizoate Injection Market Share by Type in 2022 & 2029
Figure 4. 1ml/0.3g Product Picture
Figure 5. 20ml/15.2g Product Picture
Figure 6. 20ml/12g Product Picture
Figure 7. 100ml/60g Product Picture
Figure 8. Global Meglumine Diatrizoate Injection Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 9. Global Meglumine Diatrizoate Injection Market Share by Application in 2022 & 2029
Figure 10. Hospital
Figure 11. Clinic
Figure 12. Pharmacy
Figure 13. Global Meglumine Diatrizoate Injection Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Meglumine Diatrizoate Injection Market Size (2018-2029) & (US$ Million)
Figure 15. Global Meglumine Diatrizoate Injection Sales (2018-2029) & (K Bottles)
Figure 16. Global Meglumine Diatrizoate Injection Average Price (US$/Bottle) & (2018-2029)
Figure 17. Meglumine Diatrizoate Injection Report Years Considered
Figure 18. Meglumine Diatrizoate Injection Sales Share by Manufacturers in 2022
Figure 19. Global Meglumine Diatrizoate Injection Revenue Share by Manufacturers in 2022
Figure 20. The Global 5 and 10 Largest Meglumine Diatrizoate Injection Players: Market Share by Revenue in 2022
Figure 21. Meglumine Diatrizoate Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 22. Global Meglumine Diatrizoate Injection Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 23. North America Meglumine Diatrizoate Injection Sales Market Share by Country (2018-2029)
Figure 24. North America Meglumine Diatrizoate Injection Revenue Market Share by Country (2018-2029)
Figure 25. United States Meglumine Diatrizoate Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Canada Meglumine Diatrizoate Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Europe Meglumine Diatrizoate Injection Sales Market Share by Country (2018-2029)
Figure 28. Europe Meglumine Diatrizoate Injection Revenue Market Share by Country (2018-2029)
Figure 29. Germany Meglumine Diatrizoate Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. France Meglumine Diatrizoate Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. U.K. Meglumine Diatrizoate Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Italy Meglumine Diatrizoate Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Russia Meglumine Diatrizoate Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Asia Pacific Meglumine Diatrizoate Injection Sales Market Share by Region (2018-2029)
Figure 35. Asia Pacific Meglumine Diatrizoate Injection Revenue Market Share by Region (2018-2029)
Figure 36. China Meglumine Diatrizoate Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Japan Meglumine Diatrizoate Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. South Korea Meglumine Diatrizoate Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. India Meglumine Diatrizoate Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Australia Meglumine Diatrizoate Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. China Taiwan Meglumine Diatrizoate Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Southeast Asia Meglumine Diatrizoate Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Latin America Meglumine Diatrizoate Injection Sales Market Share by Country (2018-2029)
Figure 44. Latin America Meglumine Diatrizoate Injection Revenue Market Share by Country (2018-2029)
Figure 45. Mexico Meglumine Diatrizoate Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Brazil Meglumine Diatrizoate Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Argentina Meglumine Diatrizoate Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Meglumine Diatrizoate Injection Sales Market Share by Country (2018-2029)
Figure 49. Middle East & Africa Meglumine Diatrizoate Injection Revenue Market Share by Country (2018-2029)
Figure 50. Turkey Meglumine Diatrizoate Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia Meglumine Diatrizoate Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. UAE Meglumine Diatrizoate Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Global Sales Market Share of Meglumine Diatrizoate Injection by Type (2018-2029)
Figure 54. Global Revenue Market Share of Meglumine Diatrizoate Injection by Type (2018-2029)
Figure 55. Global Meglumine Diatrizoate Injection Price (US$/Bottle) by Type (2018-2029)
Figure 56. Global Sales Market Share of Meglumine Diatrizoate Injection by Application (2018-2029)
Figure 57. Global Revenue Market Share of Meglumine Diatrizoate Injection by Application (2018-2029)
Figure 58. Global Meglumine Diatrizoate Injection Price (US$/Bottle) by Application (2018-2029)
Figure 59. Meglumine Diatrizoate Injection Value Chain
Figure 60. Meglumine Diatrizoate Injection Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock